Literature DB >> 236803

Editorial: Sulphasalazine for Crohn's diseases?

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 236803      PMCID: PMC1681889          DOI: 10.1136/bmj.2.5966.297

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  6 in total

1.  Comparison of corticosteroid and sulphasalazine therapy in ulcerative colitis.

Authors:  S C TRUELOVE; G WATKINSON; G DRAPER
Journal:  Br Med J       Date:  1962-12-29

2.  Sulphasalazine and salicylazosulphadimidine in ulcerative colitis.

Authors:  J H BARON; A M CONNELL; J E LENNARD-JONES; F A JONES
Journal:  Lancet       Date:  1962-05-26       Impact factor: 79.321

3.  Reversibility of radiological appearances during clinical improvement in colonic Crohn's disease.

Authors:  J H Jones; J E Lennard-Jones; A C Young
Journal:  Gut       Date:  1969-09       Impact factor: 23.059

4.  Medical versus operative treatment.

Authors:  G W Meeuwisse; B Hansing
Journal:  Acta Paediatr Scand       Date:  1971-05

5.  Clinical and radiologic improvement of regional enteritis and enterocolitis after treatment with salicylazosulfapyridine.

Authors:  F Goldstein; M G Murdock
Journal:  Am J Dig Dis       Date:  1971-05

6.  A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphazalazine (Salazopyrin).

Authors:  A S Dissanayake; S C Truelove
Journal:  Gut       Date:  1973-12       Impact factor: 23.059

  6 in total
  1 in total

Review 1.  Clinical pharmacokinetics of sulphasalazine.

Authors:  K M Das; R Dubin
Journal:  Clin Pharmacokinet       Date:  1976 Nov-Dec       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.